PPRS deal ‘dreadful’, says EMIG
November 26, 2013Sales and Marketing EMIG, NHS, NICE, PPRS, VBP
The Ethical Medicines Industry Group (EMIG) has slammed the new PPRS plan, calling it a ‘dreadful deal’ for its members. …
GSK expands Montrose API plant with £25m investment
November 25, 2013Manufacturing and Production GSK, Scotland, montrose
GlaxoSmithKline is planning to invest £25 million ($40m) at a facility in Scotland that will take on production of ingredients …
US regulator shows Nexavar green light
November 25, 2013Sales and Marketing Bayer, Cancer, FDA, Nexavar, Onyx, thyroid
The FDA has extended the indication of liver and kidney cancer pill Nexavar to treat late-stage differentiated thyroid cancer. It …
Cancer Research UK invests £100m in research centres
November 25, 2013Research and Development, Sales and Marketing Cancer, Cancer Research UK, UK
Cancer Research UK says it will invest over £100 million across 15 cutting-edge research centres to help get new treatments …
FDA approves Olysio
November 25, 2013Sales and Marketing FDA, Janseen, Janssen, hep C, hepc, olysio, simeprevir
US regulators have approved Janssen Pharmaceuticals’ Olysio, a new therapy to treat chronic hepatitis C virus infection, after a priority …
Patient involvement ‘increases public confidence’ in research
November 25, 2013Research and Development, Sales and Marketing hra, mori, public, rec, research
A new study has shown that public confidence in health research studies can be increased by knowing that patients have …
Hold your horses: M&A is about talent, not just pipelines
November 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, mergers, molloy, roik, rsa, talent
The morning mist is rising on the battlefield. At stake: the crown riches and glory of tomorrow’s pharma leadership. The …
Camargo Pharmaceutical Services names chief operating officer
November 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Camargo Pharmaceutical Services
Veteran healthcare executive Jim Beach has been named chief operating officer for drug development firm Camargo Pharmaceutical Services. “Jim’s history …
Gilead gets CHMP nod
November 25, 2013Research and Development, Sales and Marketing CHMP, FDA, Gilead, chc, sovaldi
The CHMP has opened the way for Gilead Sciences’ first-in-class investigational chronic hepatitis C drug Sovaldi (sofosbuvir) to get to …
E-prescribing ‘patchy at best’
November 22, 2013Medical Communications, Sales and Marketing DoH, NHS, UCL, e-prescribing
Electronic prescribing in NHS hospitals – seen as one of the cornerstones of public health provision in the future – …
Cancer app takes top prize in Janssen digital awards
November 22, 2013Medical Communications, Sales and Marketing Cancer, J&J, JJ, app, digital, px healthcare
A start-up firm established by medical scientists that develops mobile apps for cancer patients has taken first place in the …
Big data ‘road map’ launched by ABPI
November 22, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, BMA, NIHR, data, transparency
The ABPI has launched a new initiative that aims to harness the potential of big data to improve patient care …
Life makes several changes
November 22, 2013Medical Communications, Research and Development, Sales and Marketing Life, comms, creative, healthcare
Marketing communications firm Life is restructuring to advance its status as an integrated creative company. As part of this process …
Coalition launches rare disease strategy
November 22, 2013Research and Development, Sales and Marketing DoH, NHS, R&D, rare disease
The Department of Health has launched the UK’s first strategy on rare diseases as part of a bid to boost …
Lilly signs Lou Gehrig’s disease deal
November 21, 2013Research and Development, Sales and Marketing als, hill, lilly, lou gehrig
Eli Lilly & Company has signed a deal with US charity Project A.L.S. to find new treatments for the debilitating …
GSK makes £425 million Aspen sale
November 21, 2013Sales and Marketing GSK, Merck, South Africa, aspen
GlaxoSmithKline has raised £425 million with the sale of 28.2 million shares that it has in Africa’s biggest drugmaker as …
Smartphone app to aid brain injury sufferers
November 21, 2013Medical Communications brain, brain in hand, digital, glenside, smartphone, wells
Neurological rehabilitation firm Glenside are running a large-scale pilot which uses smartphone technology to improve the lives of people with …
NHS responds to Mid Staffs
November 21, 2013Sales and Marketing Francis, Mid Staffs, NHS, UK
The government has accepted 281 out of the 290 recommendations contained in the Francis report – the damning document published …
Novasep appoints president of Industrial Biotech business
November 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novasep
French processing equipment supplier Novasep has appointed Nadege Laborde as the new president of its Industrial Biotech business unit. It …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
